Skip to content

Four ways life sciences manufacturing must change after Covid-19

Pari Sanghavi, senior director, life sciences supply chain and manufacturing at Cognizant and Jim Lehane, global leader business development at Zenith discuss how manufacturing must change following Covid-19.

Four ways life sciences manufacturing must change after Covid-19
Published: | 4 min read

Pari Sanghavi, senior director, life sciences supply chain and manufacturing at Cognizant and Jim Lehane, global leader business development at Zenith discuss how manufacturing must change following Covid-19.

AR Manufacturing

Pharmaceutical and other life sciences products require some of the most complex, precise, and highly regulated processes in the manufacturing world. They require close coordination among highly skilled workers using expensive and specialised equipment. Following and documenting adherence to Good Manufacturing Practices (GMP) and proper manufacturing protocols is mandatory for life sciences manufacturers. 

The social distancing requirements to contain the Covid-19 pandemic, and the associated supply chain disruptions, has meant rapid and sudden challenges to life sciences manufacturing. Here are four ways digital tools and processes can meet these emerging needs.   

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information